Silverfin false false 30/12/2024 01/01/2024 30/12/2024 M A Rodriguez Campa 05/08/2002 13 May 2026 The principal activity of the Company is importing, selling and servicing of medical equipment. 04498804 2024-12-30 04498804 bus:Director1 2024-12-30 04498804 2023-12-31 04498804 core:CurrentFinancialInstruments 2024-12-30 04498804 core:CurrentFinancialInstruments 2023-12-31 04498804 core:Non-currentFinancialInstruments 2024-12-30 04498804 core:Non-currentFinancialInstruments 2023-12-31 04498804 core:ShareCapital 2024-12-30 04498804 core:ShareCapital 2023-12-31 04498804 core:RetainedEarningsAccumulatedLosses 2024-12-30 04498804 core:RetainedEarningsAccumulatedLosses 2023-12-31 04498804 core:LandBuildings 2023-12-31 04498804 core:ComputerEquipment 2023-12-31 04498804 core:LandBuildings 2024-12-30 04498804 core:ComputerEquipment 2024-12-30 04498804 core:CurrentFinancialInstruments core:Secured 2024-12-30 04498804 core:OtherMembersGroupNotDefinedElsewhere core:CurrentFinancialInstruments 2024-12-30 04498804 core:OtherMembersGroupNotDefinedElsewhere core:CurrentFinancialInstruments 2023-12-31 04498804 core:Non-currentFinancialInstruments core:MoreThanFiveYears 2024-12-30 04498804 core:Non-currentFinancialInstruments core:MoreThanFiveYears 2023-12-31 04498804 2022-12-31 04498804 core:AcceleratedTaxDepreciationDeferredTax 2024-12-30 04498804 core:AcceleratedTaxDepreciationDeferredTax 2023-12-31 04498804 2024-01-01 2024-12-30 04498804 bus:FilletedAccounts 2024-01-01 2024-12-30 04498804 bus:SmallEntities 2024-01-01 2024-12-30 04498804 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-30 04498804 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-30 04498804 bus:Director1 2024-01-01 2024-12-30 04498804 core:LandBuildings core:BottomRangeValue 2024-01-01 2024-12-30 04498804 core:LandBuildings core:TopRangeValue 2024-01-01 2024-12-30 04498804 core:ComputerEquipment core:TopRangeValue 2024-01-01 2024-12-30 04498804 2023-01-01 2023-12-31 04498804 core:LandBuildings 2024-01-01 2024-12-30 04498804 core:ComputerEquipment 2024-01-01 2024-12-30 04498804 core:MoreThanFiveYears 2024-01-01 2024-12-30 iso4217:GBP xbrli:pure

Company No: 04498804 (England and Wales)

ADVANCED MEDICAL EQUIPMENT LIMITED

Unaudited Financial Statements
For the financial period from 01 January 2024 to 30 December 2024
Pages for filing with the registrar

ADVANCED MEDICAL EQUIPMENT LIMITED

Unaudited Financial Statements

For the financial period from 01 January 2024 to 30 December 2024

Contents

ADVANCED MEDICAL EQUIPMENT LIMITED

COMPANY INFORMATION

For the financial period from 01 January 2024 to 30 December 2024
ADVANCED MEDICAL EQUIPMENT LIMITED

COMPANY INFORMATION (continued)

For the financial period from 01 January 2024 to 30 December 2024
Director M A Rodriguez Campa
Secretary R M Ruiz De Rodriguez
Registered office 9 Donnington Park
85 Birdham Road
Chichester
PO20 7AJ
United Kingdom
Business address Unit 4 Foundry Court
Foundry Lane
Horsham
RH13 5PY
Company number 04498804 (England and Wales)
Accountant Kreston Reeves LLP
9 Donnington Park
85 Birdham Road
Chichester
West Sussex
PO20 7AJ

ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF
THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF ADVANCED MEDICAL EQUIPMENT LIMITED

For the financial period from 01 January 2024 to 30 December 2024

ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF
THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF ADVANCED MEDICAL EQUIPMENT LIMITED (continued)

For the financial period from 01 January 2024 to 30 December 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Advanced Medical Equipment Limited for the financial period ended 30 December 2024 which comprise the Balance Sheet and the related notes 1 to 7 from the Company’s accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/regulation.

This report is made solely to the Director of Advanced Medical Equipment Limited, as a body, in accordance with the terms of our engagement letter dated 16 January 2026. Our work has been undertaken solely to prepare for your approval the financial statements of Advanced Medical Equipment Limited and state those matters that we have agreed to state to the director of Advanced Medical Equipment Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Advanced Medical Equipment Limited and its Director as a body for our work or for this report.

It is your duty to ensure that Advanced Medical Equipment Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Advanced Medical Equipment Limited. You consider that Advanced Medical Equipment Limited is exempt from the statutory audit requirement for the financial period.

We have not been instructed to carry out an audit or a review of the financial statements of Advanced Medical Equipment Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Kreston Reeves LLP

9 Donnington Park
85 Birdham Road
Chichester
West Sussex
PO20 7AJ

13 May 2026

ADVANCED MEDICAL EQUIPMENT LIMITED

BALANCE SHEET

As at 30 December 2024
ADVANCED MEDICAL EQUIPMENT LIMITED

BALANCE SHEET (continued)

As at 30 December 2024
Note 30.12.2024 31.12.2023
£ £
Fixed assets
Tangible assets 3 224,102 236,886
224,102 236,886
Current assets
Stocks 0 1,375
Debtors 4 48,268 16,344
Cash at bank and in hand 1,144 53,073
49,412 70,792
Creditors: amounts falling due within one year 5 ( 225,116) ( 246,211)
Net current liabilities (175,704) (175,419)
Total assets less current liabilities 48,398 61,467
Creditors: amounts falling due after more than one year 6 ( 79,820) ( 36,558)
Provision for liabilities 7 ( 8,277) ( 10,535)
Net (liabilities)/assets ( 39,699) 14,374
Capital and reserves
Called-up share capital 100 100
Profit and loss account ( 39,799 ) 14,274
Total shareholders' (deficit)/funds ( 39,699) 14,374

For the financial period ending 30 December 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Advanced Medical Equipment Limited (registered number: 04498804) were approved and authorised for issue by the Director on 13 May 2026. They were signed on its behalf by:

M A Rodriguez Campa
Director
ADVANCED MEDICAL EQUIPMENT LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 01 January 2024 to 30 December 2024
ADVANCED MEDICAL EQUIPMENT LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 01 January 2024 to 30 December 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Advanced Medical Equipment Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 9 Donnington Park, 85 Birdham Road, Chichester, PO20 7AJ, United Kingdom. The principal place of business is Unit 4 Foundry Court, Foundry Lane, Horsham, RH13 5PY.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The director has assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Reporting period length

The financial statements cover the period to 30 December 2024. The comparative period ended on 31 December 2023.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Employee benefits

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Statement of Income and Retained Earnings in respect of pension costs and other post-retirement benefits is the contributions payable in the financial period. Differences between contributions payable in the financial period and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Finance costs

Finance costs are charged to the Statement of Income and Retained Earnings over the term of the debt using the effective interest method so the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Land and buildings 10 - 50 years straight line
Computer equipment 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Borrowing costs

Borrowing costs that are directly attributable to acquisition, construction or production of qualifying assets, are capitalised as part of the cost of those assets. Capitalisation begins when both finance costs and expenditures for the asset are being incurred and activities that are necessary to get the asset ready for use are in progress. Capitalisation ceases when substantially all the activities that are necessary to get the asset ready for use are complete.

All other borrowing costs are recognised in profit or loss in the period in which they are incurred.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Dividends and distributable reserves

At the time the dividends were paid, the Company did not have sufficient distributable reserves, resulting in negative reserves. In accordance with section 830 of the Companies Act 2006, dividends may only be paid out of distributable profits, and accordingly the dividends paid may not have been lawful.

The director and shareholders are aware of the Company’s reserves position. The dividends that are deemed unlawful may be repayable under sections 847–849 of the Companies Act 2006. The directors are reviewing the position and intend to take appropriate action to ensure compliance with the Companies Act 2006 in future periods. No adjustment has been made in these financial statements in respect of the potential repayment of dividends.

2. Employees

Period from
01.01.2024 to
30.12.2024
Year ended
31.12.2023
Number Number
Monthly average number of persons employed by the Company during the period, including the director 2 2

3. Tangible assets

Land and buildings Computer equipment Total
£ £ £
Cost
At 01 January 2024 287,347 106,857 394,204
Additions 2,546 8,112 10,658
Disposals 0 ( 5,991) ( 5,991)
At 30 December 2024 289,893 108,978 398,871
Accumulated depreciation
At 01 January 2024 89,574 67,744 157,318
Charge for the financial period 5,950 17,492 23,442
Disposals 0 ( 5,991) ( 5,991)
At 30 December 2024 95,524 79,245 174,769
Net book value
At 30 December 2024 194,369 29,733 224,102
At 31 December 2023 197,773 39,113 236,886

4. Debtors

30.12.2024 31.12.2023
£ £
Trade debtors 39,425 6,482
Prepayments 2,126 3,146
Other debtors 6,717 6,716
48,268 16,344

5. Creditors: amounts falling due within one year

30.12.2024 31.12.2023
£ £
Bank loans (secured) 3,273 3,172
Trade creditors 54,503 82,655
Amounts owed to connected persons 6,125 0
Amounts owed to director 10,655 2,072
Other loans (secured) 5,616 4,474
Accruals and deferred income 21,090 20,985
Taxation and social security 109,387 121,264
Other creditors 14,467 11,589
225,116 246,211

Details of security provided:

Bank loans are backed by the Government. Other loans are secured by way of a fixed charge over the freehold property, fixed plant and machinery and all present and future book and other debts, and a floating charge over moveable plant and machinery and fixtures and fittings.

6. Creditors: amounts falling due after more than one year

30.12.2024 31.12.2023
£ £
Bank loans (secured) 33,363 27,109
Other loans (secured) 46,457 9,449
79,820 36,558

Amounts repayable after more than 5 years are included in creditors falling due over one year:

30.12.2024 31.12.2023
£ £
Bank loans (secured) 10,000 9,449
Other loans (secured) 11,770 0
21,770 9,449

Bank loans are backed by the Government. Other loans are secured by way of a fixed charge over the freehold property, fixed plant and machinery and all present and future book and other debts, and a floating charge over moveable plant and machinery and fixtures and fittings.

7. Deferred tax

30.12.2024 31.12.2023
£ £
At the beginning of financial period/year ( 10,535) ( 3,707)
Credited/(charged) to the Statement of Income and Retained Earnings 2,258 ( 6,828)
At the end of financial period/year ( 8,277) ( 10,535)

The deferred taxation balance is made up as follows:

30.12.2024 31.12.2023
£ £
Accelerated capital allowances ( 8,277) ( 10,535)